Iovance Biotherapeutics Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

NasdaqGM:IOVA Recent Insider Transactions by Companies or Individuals
Date	Value	Name	Entity	Shares	Max Price
20 Feb 24	BuyUS$292,800	Iain Dukes	Individual	32,000	US$9.15
20 Feb 24	BuyUS$2,287,500	Merrill McPeak	Individual	250,000	US$9.15
20 Feb 24	BuyUS$45,750,000	Wayne Rothbaum	Individual	5,000,000	US$9.15
18 Sep 23	BuyUS$55,600	Merrill McPeak	Individual	10,000	US$5.56
15 Sep 23	BuyUS$26,500,000	Wayne Rothbaum	Individual	5,000,000	US$5.30

Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.

Ownership Breakdown

What is the ownership structure of IOVA?
Owner Type	Number of Shares	Ownership Percentage
Private Companies	25,994	0.00929%
Individual Insiders	29,171,880	10.4%
General Public	31,304,282	11.2%
VC/PE Firms	43,270,094	15.5%
Institutions	176,060,472	62.9%

Dilution of Shares: Shareholders have been diluted in the past year, with total shares outstanding growing by 24.7%.

Top Shareholders

Top 25 shareholders own 69.35% of the company

Ownership	Name	Shares	Current Value	Change %	Portfolio %
10%	Wayne Rothbaum	28,067,333	US$281.0m	21.7%	no data
8.9%	The Vanguard Group, Inc.	24,915,300	US$249.4m	9.22%	no data
8.58%	MHR Fund Management LLC	23,997,103	US$240.2m	20%	27.41%
7.12%	BlackRock, Inc.	19,929,702	US$199.5m	4.5%	no data
6.89%	Perceptive Advisors LLC	19,272,991	US$192.9m	60.9%	3.87%
4.18%	Avoro Capital Advisors LLC	11,700,000	US$117.1m	74.6%	1.52%
3.72%	State Street Global Advisors, Inc.	10,402,719	US$104.1m	-36.7%	no data
2.35%	T. Rowe Price Group, Inc.	6,581,203	US$65.9m	101%	0.01%
1.97%	Geode Capital Management, LLC	5,506,617	US$55.1m	9.32%	no data
1.84%	Artisan Partners Limited Partnership	5,138,222	US$51.4m	6.43%	0.04%
1.25%	Soleus Capital Management, L.P.	3,505,000	US$35.1m	532%	3.42%
1.25%	Voloridge Investment Management, LLC	3,494,184	US$35.0m	255%	0.13%
1.16%	Pictet Asset Management Limited	3,250,554	US$32.5m	-38.2%	0.02%
1.06%	Summit Partners Public Asset Management, LLC	2,965,987	US$29.7m	0%	1.29%
1.03%	Dimensional Fund Advisors LP	2,871,498	US$28.7m	-18.4%	no data
0.94%	Goldman Sachs Group, Investment Banking and Securities Investments	2,627,731	US$26.3m	-6.55%	0.01%
0.94%	Hood River Capital Management LLC	2,624,238	US$26.3m	31.1%	0.57%
0.87%	JP Morgan Asset Management	2,446,657	US$24.5m	-3.25%	no data
0.84%	D. E. Shaw & Co., L.P.	2,352,166	US$23.5m	993%	0.03%
0.8%	Northern Trust Global Investments	2,227,344	US$22.3m	2.04%	no data
0.79%	BioImpact Capital LLC	2,200,000	US$22.0m	-33.1%	3.7%
0.76%	Palo Alto Investors LP	2,112,811	US$21.1m	0.29%	2.74%
0.72%	Principal Global Investors, LLC	2,006,044	US$20.1m	-23.9%	0.01%
0.7%	Morgan Stanley, Investment Banking and Brokerage Investments	1,958,129	US$19.6m	-36.5%	no data
0.68%	Charles Schwab Investment Management, Inc.	1,913,100	US$19.2m	9.51%	no data